Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
843 participants
OBSERVATIONAL
2012-07-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Buprenorphine on Postoperative Endodontic Analgesia
NCT03268278
Postoperative Pain Management in Hospital and Following Discharge From Hospital.
NCT01907178
RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief
NCT02046382
A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery
NCT04015908
PO vs. IV Acetaminophen Given Perioperatively for 24 hr Post-op Pain Control Following Total Hip or Knee Replacement
NCT02244619
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NSAID only
Subjects have their pain treated post-ED care with NSAID medication alone
No interventions assigned to this group
Opioid only
Subjects have their pain treated post-ED care with opioid medication alone
No interventions assigned to this group
NSAID + Opioid
Subjects have their pain treated post-ED care with NSAID medication and opioid as PRN rescue analgesia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Eligible diagnoses:
musculoskeletal etiologies: acute extremity fractures sprains/strains acute gouty arthritis visceral etiologies: renal colic dysmenorrhea
2. Age GTE 18 years;
3. Decision to discharge from ED to community already made;
4. Decision to give SPRIX, opioid, OR SPRIX + opioid rescue already made;
5. Treating clinician deems patient appropriate for continued analgesic management as an outpatient for the next 3-5 days;
6. Patient has ready touch-tone (mobile or land line) telephone access, provides number (and back-up number, if possible) and agrees (verbal or written consent as mandated by site) to answer and comply with brief IVR questionnaires daily for next 4 days.
Exclusion Criteria
1. Patient admitted or placed on observation status from ED;
2. Patient unwilling or unable to comply with telephonic follow-up;
3. Fracture that requires surgical repair (even if at a later date);
4. Patient has diagnosis of any chronic pain syndrome;
5. Patient already routinely takes NSAID or opioid agent;
6. Treating clinician has reasonable suspicion of drug-seeking behavior or noncompliance;
7. Nasal abnormality or illness that could affect the absorption of intranasal medication (such as: nasal discharge, rhinitis, acute upper respiratory infection, acute epistaxis, nasal polyp, nasal tumor).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Regent, Inc.
INDUSTRY
Radnor Registry Research, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles V Pollack, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Knox Todd, MD
Role: STUDY_DIRECTOR
MD Anderson
Debra Diercks, MD
Role: STUDY_DIRECTOR
UC Davis
Sharon Mace, MD
Role: STUDY_DIRECTOR
The Cleveland Clinic
Stephen Thomas, MD
Role: STUDY_DIRECTOR
Univ Oklahoma
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
LSU Medical Center
New Orleans, Louisiana, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
Cleveland Clinic
Cleveland, Ohio, United States
University of Oklahoma HSC
Tulsa, Oklahoma, United States
Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Ben Taub General Hospital
Houston, Texas, United States
University of Texas HSC at Houston
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RRR-LUIT-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.